- Home
- RGNX vs UHT Comparison
RGNX vs UHT Comparison
Compare RGNX & UHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RGNX | UHT |
|---|---|---|
| Founded | 2008 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 528.6M | 595.1M |
| IPO Year | 2015 | 1995 |
Fundamental Metrics
Financial Performance| Metric | RGNX | UHT |
|---|---|---|
| Price | $10.37 | $43.94 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 1 |
| Target Price | $28.75 | ★ $43.00 |
| AVG Volume (30 Days) | ★ 2.9M | 286.1K |
| Earning Date | 05-05-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 7.33% |
| EPS Growth | ★ 18.08 | N/A |
| EPS | N/A | ★ 0.36 |
| Revenue | $10,393,000.00 | ★ $99,190,000.00 |
| Revenue This Year | $51.21 | $2.12 |
| Revenue Next Year | $19.08 | $2.94 |
| P/E Ratio | ★ N/A | $121.44 |
| Revenue Growth | ★ 126.48 | 0.18 |
| 52 Week Low | $5.46 | $35.26 |
| 52 Week High | $16.19 | $46.30 |
Technical Indicators
Market Signals| Indicator | RGNX | UHT |
|---|---|---|
| Relative Strength Index (RSI) | 45.33 | 58.68 |
| Support Level | $7.84 | $38.89 |
| Resistance Level | $10.56 | $44.70 |
| Average True Range (ATR) | 1.24 | 1.15 |
| MACD | -0.58 | -0.04 |
| Stochastic Oscillator | 25.60 | 40.31 |
Price Performance
Historical ComparisonAbout RGNX REGENXBIO Inc.
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.
About UHT Universal Health Realty Income Trust
Universal Health Realty Income Trust is a healthcare REIT. The company is engaged in the business of investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. The company actively manages a portfolio of healthcare and human service facilities. The revenue and net income are generated from the operation of the investment portfolio, located throughout the United States.